BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Prostate, Human chorionic gonadotropin, Doxorubicin, rs7903146, ZBTB7A, Coagulation)
Bookmark Forward

QuickView for STAT3 (gene)


Body Atlas

Most Correlated Tissues

  1. Pericardium
  2. Neutrophil of bone marrow
  3. Leukocyte (polymorphonuclear) of peripheral blood
  4. Peritoneum
  5. Skeletal muscle psoas
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Congenital hypergammaglobulinemia
  2. Hereditary white blood cell disorder
  3. Cardiac transplant rejection
  4. Complications of pregnancy, childbirth and the puerperium
  5. Pneumocystosis
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. IL10 protein, human
  2. Cancer Vaccines
  3. cresidine
  4. IL20 protein, human
  5. Oxymetazoline
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. FIGLA
  2. STAT3
  3. RABGGTA
  4. IL11RA
  5. Stat5a
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Discovery of STAT3 Inhibitors: Recent Advances and Future Perspectives.
  2. STAT3 signaling in B cells controls germinal center zone organization and recycling.
  3. circPTPN22 attenuates immune microenvironment of pancreatic cancer via STAT3 acetylation.
  4. STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target.
  5. Perspective: mitochondrial STAT3 in cardioprotection.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Investigating STAT3 as a Driver of Pathology in Periodontitis
  2. STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastati…
  3. STAT3 DECOY in Head and Neck Cancer
  4. STAT3 in T Cells: At The Crossroads of Inflammation and Cancer
  5. Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.